Diabetes is a scourge that affects just over one in 10 Americans—more than 34 million people. But those who seek out supplements to support healthy blood glucose levels may encounter some brands making unlawful claims about their products, federal regulators allege.
The FDA and FTC last week sent warning letters in this vein to 10 companies, alleging the companies were illegally selling dietary supplements that claim to cure, treat, mitigate or prevent diabetes—a disease that impairs the body’s ability to produce or respond to insulin, which in turn causes sugars to build up in the blood.
Warning letters were issued to: Live Good Inc.; Pharmaganics LLC; Lysulin Inc.; Nuturna International LLC; Phytage Labs; Ar-Rahmah Pharm LLC; Metamune Inc.; Holistic Healer & Wellness Center Inc.; Radhanite LLC; and Aceva LLC.
The agencies allege some product marketing and branding by companies targeted by the letters is in violation of the Federal Food, Drug, and Cosmetic Act (FD&C). Under FD&C, products that claim they can diagnose, cure, treat, mitigate or prevent disease are considered drugs and are subject to FDA scrutiny. Regulators wrote the products cited in the warning letters are considered unapproved new drugs and thus have not been evaluated by FDA to be safe and effective for their intended use.
Examples cited by the agencies in the letters include:
– “(Berry Gen Sugar Support) helps control…